Advertisement
Screener

GeneDx Holdings Corp. (WGS) Payments for Repurchase of Other Equity

GeneDx Holdings Corp. Payments for Repurchase of Other Equity

GeneDx Holdings Corp. (WGS) reported Payments for Repurchase of Other Equity of $230.66 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.

Discontinued › Cash Flow › Financing Activities

us-gaap:PaymentsForRepurchaseOfOtherEquity · last filed 2022-03-14

  • 2021-09-30: Payments for Repurchase of Other Equity 9 month $230.66M.
  • 2021-07-22: Payments for Repurchase of Other Equity $230.00M.
  • 2020-09-30: Payments for Repurchase of Other Equity 9 month $0.00.
Period endPayments for Repurchase of Other EquityPayments for Repurchase of Other Equity 9 month
2021-09-30$230.66M
10-Q · filed 2021-11-15
2021-07-22$230.00M
10-K · filed 2022-03-14
2020-09-30$0.00
10-Q · filed 2021-11-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
Pennant Group, Inc. (PNTG)United States$1.386B39.84
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Omada Health, Inc. (OMDA)United States$1.207B309.08
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B